Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Jun 16, 2019 5:30pm

87 Views

Post# 29830572

RE:RE:RE:RE:Transcript of Dr. Jewett's AGM Presentation - June 2018

I agree with Vestor111 that a R/S won't be dramatic, compared to other desperate R/S where nothing works.

But again, if there's a GBM jv pending, that would bring upfront payment. So the share price would go higher because of that and because of the big pharma name.

Bullboard Posts

Rich TV Live's Stocks to Watch this week (June 21, 2024)